Skip to main content
Log in

Waldenström’s Macroglobulinemia Associated With AA Amyloidosis

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

It is widely accepted that amyloidosis in Waldenström’s macroglobulinemia (WM) is exclusively due to amyloid light-chain deposition. However, only a small number of previous reports have actually characterized the type of amyloid in WM.We now report the third patient with WM and amyloid A protein (AA) amyloidosis. This patient developed malabsorption, nephrotic syndrome, and orthostatic hypotension. AA was immunohistochemically demonstrated in the rectal biopsy. In conjunction with previous examples of AA amyloidosis, the present report raises the possibility that AA amyloidosis may also occur in WM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dimopoulos MA, Alexanian R. Waldenström’s macroglobulinemia.Blood. 1994;83:1452–1459.

    PubMed  CAS  Google Scholar 

  2. Gillmore JD, Hawkins PN, Pepys MB. Amyloidosis: a review of recent diagnostic and therapeutic developments.Br J Haematol. 1997;99:245–256.

    Article  CAS  PubMed  Google Scholar 

  3. Urieli-Shoval S, Cohen P, Eisenberg S, Matzner Y. Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium.J Histochem Cytochem. 1998;46:1377–1384.

    Article  CAS  PubMed  Google Scholar 

  4. Orfila C, Rakotoarivony J, Segonds A, Suc JM. Immunofluorescence study of “non-idiopathic” renal amyloidosis.Hum Pathol. 1983;14:362–367.

    Article  CAS  PubMed  Google Scholar 

  5. Hirose H, Takemura Y, Honma S, et al. Nephrotic syndrome associated with generalized amyloidosis and IgM-monoclonal proteinemia.Jpn J Med. 1991;30:130–134.

    Article  CAS  PubMed  Google Scholar 

  6. Faa G, Van Eyken P, De Vos R, et al. Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis.J Hepatol. 1991;12:75–82.

    Article  CAS  PubMed  Google Scholar 

  7. Julien J, Vital C, Vallat JM, et al. IgM demyelinative neuropathy with amyloidosis and biclonal gammopathy.Ann Neurol. 1984;15:395–399.

    Article  CAS  PubMed  Google Scholar 

  8. Gertz MA, Kyle RA, Noel P. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström’s macroglobulinemia.J Clin Oncol. 1993;11:914–920.

    Article  CAS  PubMed  Google Scholar 

  9. Jones CH, Kanagasundaram NS, Coral AP, Coyne JD, Will EJ. Combined Waldenstrom’s macroglobulinaemia associated AL and beta-2-microglobulin amyloidosis.Nephrol Dial Transplant. 1997;12:2708–2712.

    Article  CAS  PubMed  Google Scholar 

  10. Zatloukal P, Bezdicek P, Schimonova M, Havlicek F, Tesarova P, Slovakova A. Waldenstrom’s macroglobulinemia with pulmonary amyloidosis.Respiration. 1998;65:414–416.

    Article  CAS  PubMed  Google Scholar 

  11. Strege RJ, Saeger W, Linke RP. Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series.Virchows Arch. 1998;433:19–27.

    Article  CAS  PubMed  Google Scholar 

  12. Møyner K, Sletten K, Husby G, Natvig JB. An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenström’s macroglobulinemia and amyloidosis.Scand J Immunol. 1980;11:549–554.

    Article  PubMed  Google Scholar 

  13. Ogami Y, Takasugi M, Soejima M. et al. Waldenstrom’s macroglobulinemia associated with amyloidosis and crescentic glomerulonephritis.Nephron. 1989;51:95–98.

    Article  CAS  PubMed  Google Scholar 

  14. Wright JR, Calkins E, Humphrey RL. Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.Lab Invest. 1977;36:274–281.

    PubMed  CAS  Google Scholar 

  15. Ordi J, Grau JM, Junque A, Nomdedeu B, Palacin A, Cardesa A. Secondary (AA) amyloidosis associated with Castleman’s disease.Am J Clin Path. 1993;100:394–397.

    Article  CAS  PubMed  Google Scholar 

  16. Ikeda S, Chisuwa H, Kawasaki S, et al. Systemic reactive amyloidosis associated with Castleman’s disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.J Clin Pathol. 1997;50:965–967.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Husby G. Treatment of amyloidosis and the rheumatologist. State of the art and perspectives for the future.Scand J Rheumatol. 1998;7:161–165.

    Article  Google Scholar 

  18. Yan SD, Zhu H, Zhu A, et al. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.Nature Med. 2000;6:643–651.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. M. Cohen.

About this article

Cite this article

Gardyn, J., Schwartz, A., Gal, R. et al. Waldenström’s Macroglobulinemia Associated With AA Amyloidosis. Int J Hematol 74, 76–78 (2001). https://doi.org/10.1007/BF02982553

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02982553

Key words

Navigation